Research Article | | Peer-Reviewed

COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia

Received: 28 March 2025     Accepted: 23 April 2025     Published: 29 May 2025
Views:       Downloads:
Abstract

Background: The coronavirus killed millions of people globally and was deemed a public health emergency on March 11, 2020. Many nations have put strict regulations in place. Mass vaccinations to protect the public from COVID-19 have been in place since December 2020. To stop viruses from spreading, community immunizations against COVID-19 are crucial. However, there is currently no information available on Gilgel Beles town's community's adoption of the COVID-19 vaccination. Objective: The objective of this study is to assess the level of acceptance of COVID-19 vaccination and its associated factors among communities in Gilgel Beles town, Metekel zone, North West Ethiopia. Methodology: Community-based cross-sectional study was employed between April 20/2022, and May 20/ 2022, in Gilgel Beles town. A systematic random sampling technique was used to choose 418 households in the town. After obtaining the ethical clearance sheet, Data was gathered through face-to-face interviews at their home. Before being moved to SPSS version 22 for analysis, the data were coded, cleaned, recorded, and entered into Epidata 4. The relationship between independent and dependent variables was investigated using bivariate logistic regression analysis. A variable in the multiple logistic regression models with a p-value ≤0.05 was considered statistically significant. Results: Of 415 respondents, above half of them, 255 (61.4%), were accepted to take the COVID-19 vaccine if available. Age (P-value=0.000), History of vaccine adverse effects (AOR=.3.63, 95%, CI: 1.38, 9.55), Cigarette smoking practice (AOR=3.47, 95% CI: 1.45, 8.27), Friends have been diagnosed with COVID-19 (P-value=0.000) and type of media (P=0.016) were significantly associated with acceptance of COVID-19 vaccine. Conclusion: The prevalence of COVID-19 vaccination acceptance was not high enough. The engagement of religious organizations and religious leaders to promote the advantages of COVID-19 vaccination to their followers and promotion through community radio should be implemented to increase COVID-19 vaccination acceptance.

Published in Science Journal of Public Health (Volume 13, Issue 3)
DOI 10.11648/j.sjph.20251303.11
Page(s) 106-113
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

COVID-19, Vaccine, Acceptance, Gilgel Bless, Ethiopia

1. Background
The world has been confronted with a new and powerful threat in the form of COVID-19 . Although coronaviruses are not new to the medical sciences, the SARS outbreak, a novel fifth kind of coronavirus, is now being studied for its characteristics and changing epidemiology. The strain of COVID-19 that is now in use is novel and has never been found in a person. Animal-to-human transmission was suggested early on in the Wuhan outbreak when it was revealed that many of the patients had some connection to a sizable seafood and animal market. Person-to-person dissemination, however, was explained by a growing proportion of patients who said they had never been exposed to animal markets .
Since its declaration as a public health emergency on March 11, 2020, the coronavirus pandemic has claimed millions of lives globally. To slow the spread of the virus, many nations have imposed strict policies, including face masks, social distancing, and even nationwide lockdowns. To protect the populace from COVID-19, widespread vaccination campaigns have been underway throughout Europe and America since December 2020. The introduction of the Oxford-AstraZeneca viral vector vaccine and the mRNA Pfizer-Biotech vaccine represents the biggest immunization effort in developed nations .
Ethiopian officials decided to use the COVAX Facility to administer the AstraZeneca COVID-19 vaccine. Ethiopia got 2.2 million doses of the COVID-19 vaccine from COVAX on March 7, one year ago. The COVID-19 vaccination was introduced on March 13, 2021. Over 20.5 million people have received the entire vaccination, and over 21.5 million people have received at least one dose. In order to reach a larger percentage of the population, efforts are being made to boost vaccination uptake .
2. Methods
2.1. Study Area and Period
The study will be conducted in Gilgel Beles town between April 20 and May 20/2014. Gilgel Beles town is located in the Metekel zone of Benishangul Gumuz regional state at a distance of 550 km from Addis Ababa and 378 Km from the regional capital, Assosa. Gilgel Beles town was founded in 2000. Its population is estimated 15, 220 in 2013 EFY. From this, 7,786 are female and 7434 are male. There are two administrative Keble and four Ketena in the towns administrative. The health care access in the town is dependent on one public healthcare facility and four private healthcare facilities.
2.2. Study Design
Community-based cross-sectional study design was employed.
2.3. Source Population
All households found in Gilgel Beles town, Metekel zone, North West Ethiopia, were the source population of this study.
2.3.1. Study Population
All randomly selected individuals were the study population of this study.
2.3.2. Inclusion and Exclusion Criteria
Individuals aged ≥18 years will be included in this study, and people who are incompetent during the period of data collection and Covid-19 vaccinated individuals were excluded.
2.4. Sample Size Determination
Since there has been prior research conducted on the acceptance COVID-19 vaccine in Ethiopia, the prevalence (P) of acceptance was 45% . With the following considerations in mind, the sample size was calculated using the single population proportion formula with a marginal error of 0.05, a 95% confidence interval, and a p-value of 0.5. Assume a 10% non-response rate.
2.5. Sampling Technique and Procedure
The respondents were taken from the sampled households. A systematic random sampling technique was used to choose households in the town; the first household will be selected using a simple random sampling technique, and then others will be selected at every 8th interval until the required sample size is reached. If there was more than one individual who fulfilled the inclusion criteria in one household, one respondent was selected with a simple random sampling technique.
2.6. Data Collection Tool and Procedure
A structured questionnaire was used to capture quantitative data. The questionnaire has five parts: 1) Socio-Demographic Characteristics, 2) Health condition, 3) COVID-19 experience, 4) COVID-19 vaccine acceptance, and 5) Use of broadcast media. Questions were and adapted from previously published studies . After providing consent to the participants, Face to face interview was administered to the randomly selected respondents with a structured questionnaire.
2.7. Data Processing and Analysis
Before being moved to SPSS window version 22 for analysis, the data were coded, cleaned, recorded, and entered into Epidata version 4. A table, figure, and statement were used to present the data. The relationship between independent and dependent variables was investigated using bivariate logistic regression analysis. To control for possible confounding, all variables in the bivariate logistic regression model with a p-value <0.25 were added to the multivariable logistic regression model, and variables in the multiple logistic regression model with a p-value ≤0.05 will be considered statistically significant.
2.8. Data Quality Control
To ensure the quality of data, the data collection tool was reviewed by the expertise group, and one day of training for data collectors was given before the beginning of the actual data collection day. All filled questionnaires were checked immediately after each session of data collection by the supervisors daily for completeness. Before analyzing the data was cleaned thoroughly to check for completeness, and data was entered with the help of Epi-info to minimize error during entry.
2.9. Variables
2.9.1. Dependent Variable
Acceptance of the COVID-19 vaccine.
2.9.2. Independent Variable
1. Sociodemographic variables;
2. Health condition;
3. Experience of Covid-19;
4. Use of Media.
2.10. Operational Definition
COVID-19 vaccine acceptance is defined as the willingness to take the vaccine. Accordingly, the participants will be asked about their willingness to accept the vaccine; the possible answers will be “Yes” or “No.” A score of “1” was given for Yes, and a score of “0” was given for No .
3. Results and Discussion
3.1. Socio-Demographic Characteristics
415 respondents participated in this study with a 99.2% response rate. A majority, 206 (49.6%) of respondents were found in the 18-29 age category, and 224 (54%) of the respondents were females. Above half of the respondents, 260 (69.9%) of respondents were married. One-third of the respondents’ educational status, 129 (31.1%), in the study were college and above (Table 1, p-18, 19).
Table 1: Socio-demographic characteristics of the respondent in Gilgel Beles town, Metekel zone, Benishangul-Gumuz regional state, 2022 (p-18-19).
Table 1. Sociodemographic characteristics of the respondent in Gilgel Beles town, Metekel zone, Benishangul-Gumuz regional state, 2022 (P-11).

Socio-demographic characteristics of the respondent

Frequency

Percent

Age

18-29

206

49.6

30-49

147

35.5

>49

62

14.9

Sex

Male

191

46.0

Female

224

54.0

Religion

Orthodox

256

61.7

Muslim

92

22.2

Protestant

56

13.5

Catholic

11

2.7

Marital status

Single

125

30.1

Married

290

69.9

Educational status

Unable to read and write

96

23.1

Able to read and write

64

15.4

Primary education

51

12.3

Secondary school

75

18.1

College and above

129

31.1

Occupation

Student

85

20.5

Employee

70

16.9

Unemployed

44

10.6

Homemaker

94

22.7

Informal job

113

27.2

Healthcare worker

9

2.2

3.2. Current Health Status and Vaccination History of Respondents
The majority of the respondents, 401 (96.6%), had felt healthy during the time of the interview. Only 34 (8.2%) of the respondents had a history of previous vaccine rejection. The history of Previous Vaccine adverse effects is reported by only 24 (5.8%) of the respondents. About one in eight respondents had a chronic illness unfollow-up during the time of data collection. The majority of the respondents, 335 (80.9%), were vaccinated during childhood. Cigarette smoking practice was reported by about one-third of the respondents, 29 (7%) (Table 2, P-20).
Table 2. Current health condition and vaccination history of the respondent in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-12).

Health condition and vaccination history of the respondent

Frequency

Percentage

Overall health status

Healthy

401

96.6

Not healthy

14

3.4

History of previous vaccine rejection

Yes

34

8.2

No

381

91.8

History of Vaccine severe adverse effects

Yes

24

5.8

No

391

94.2

Chronic illness

Yes

62

14.9

No

353

85.1

Vaccination during childhood

Yes

335

80.9

No

80

19.1

Cigarette Smoking

Yes

29

7.0

No

386

93.0

Table 2 Current health condition and vaccination history of the respondent in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-20).
3.3. Participants' Experience of COVID-19 Infection
The majority of the respondents, 403 (97.1%), had no contact history with COVID-19 patients. Only a few of the respondents, 47 (11.3%), had undergone a COVID-19 test. A positive result was reported by the majority of the respondents who had undergone a COVID-19 test (Table 3, P-20).
Table 3. Respondent’s experience with COVID-19 infection in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-12).

Respondent’s experience with COVID-19 infection

Frequency (N=415)

Percentage (%)

Contact history with a COVID-19 patient

Yes

12

2.9

No

403

97.1

Households have been diagnosed with COVID-19

Yes

45

10.8

No

370

89.2

Relatives have been diagnosed with COVID-19

Yes

46

11.1

No

369

88.9

Friends have been diagnosed with COVID-19

Yes

65

15.7

No

350

84.3

Have tested for COVID-19

Yes

47

11.3

No

368

88.7

COVID-19 test result (N=47)

Positive

39

82.9

Negative

8

17.1

Heard about the COVID-19 vaccine

Yes

392

94.5

No

23

5.5

Table 3 Respondent’s experience with COVID-19 infection in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-20).
3.4. Acceptance of the COVID-19 Vaccine
Above half of the respondents, 255 (61.4%), were accepted to take the COVID-19 vaccine if available. While 160 (38.6%) of the respondents were not accepted to take the COVID-19 vaccine if available (Figure 1, P-18).
Figure 1. Acceptance of COVID-19 vaccine in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-12).
Figure 1: Acceptance of the COVID-19 vaccine in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (P-18).
3.5. Reasons for Non-Acceptance of COVID-19 Vaccines
Of 162 respondents, 44 (27.3%) and 42 (26.1%) of the respondents were concerned about to fear of adverse effects of the vaccine and Unreliable due to religious reasons as the main reason for non-willingness to take the COVID-19 vaccine, respectively (Table 4, P-21).
Table 4. Reasons for Non-Acceptance of COVID-19 Vaccines among Respondents in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (N=415) (P-13).

Reasons for not taking the COVID-19 vaccine

Frequency (N=161)

Percentage

Inadequate data about the safety of the vaccine

27

16.8

Fear of the adverse effects of the vaccine

44

27.3

A concern about the vaccine being ineffective

1

.6

The vaccine causing COVID-19

2

1.2

Prefer other ways of protection

10

6.2

Prior adverse reaction to any vaccine

27

16.8

Unreliable, due to short time for development

8

5

Unreliable, due to religious reasons

42

26.1

Table 4: Reasons for Non-Acceptance of COVID-19 Vaccines among Respondents in Gilgel Beles town, Metekel zone, Benishangul-Gumuz regional state, 2022 (N=415) (P-21).
3.6. Factors Associated with Acceptance of COVID-19 Vaccines
Age, history of vaccine adverse effects, Cigarette smoking, friends who have been diagnosed with COVID-19, and use of media were all found to be significantly correlated with acceptance of the COVID-19 vaccines in a multivariable logistic regression. COVID-19 vaccines were more likely to be accepted by those who have no history of vaccine adverse effects (AOR=.3.63, 95% CI: 1.38, 9.55). Another factor linked to COVID-19 vaccine acceptance was one’s Cigarette smoking practice. Those who practice cigarette smoking were three times more likely than those with do not practice cigarette smoking to accept the COVID-19 vaccine (AOR=3.47, 95% CI: 1.45, 8.27) (Table 5, P-21, 22).
Table 5 Factors Associated with Acceptance of COVID-19 Vaccine in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (N=415) (P-21, 22).
Table 5. Factors Associated with Acceptance of COVID-19 Vaccine in Gilgel Beles town, Metekel zone, Benishangul Gumuz regional state, 2022 (N=415) (p-13).

Variable

Category

Frequency (%)

COR with 95% CI

AOR with 95% CI

P-value

Age

18-29

206 (49.6%)

4.99 (2.71, 9.19)

0.68 (0.41, 1.13)

0.135

30-49

147 (35.4%)

3.31 (1.77, 6.21)

0.2 (0.09, 0.43)

0.000*

>49

62 (14.9%)

1

1

History of vaccine adverse effects

No

391 (94.2%)

0.21 (0.10, 0.44)

3.63 (1.38, 9.55)

0.000*

Yes

24 (5.8%)

1

1

Cigarette smoking

No

386 (93%)

1

1

Yes

29 (7%)

2.81 (1.29, 6.12)

3.47 (1.45, 8.27)

0.005*

Friends have been diagnosed with COVID-19

No

350 (84.3%)

1

1

Yes

75 (15.7%)

0.21 (0.10, 0.44)

0.19 (0.08, 0.43)

0.000*

Type of media

Television

242 (58.3%)

0.28 (0.13, 0.58)

0.63 (0.28, 1.43)

0.273

Radio

37 (8.9%)

0.72 (0.44, 1.17)

0.51 (0.30, 0.88)

0.016*

Social media

99 (23.9%)

0.36 (0.18, 0.72)

0.56 (0.26, 1.20)

0.136

Magazine

37 (8.9%)

1

1

4. Discussion
In Ethiopia, COVID-19 vaccines have been launched as “the perfect cure” for bringing the current pandemic to an end. Following the publication of multiple clinical trials with encouraging findings, several nations have approved the use of particular vaccinations in immunization programs . The purpose of this study was to ascertain the respondents' estimates of COVID-19 vaccination acceptability and related parameters in Gilgel Beles, Metekel zone. This study indicated that 61.4% of people accepted the COVID-19 vaccination.
According to the current study's findings, 189 participants (45.5%) said they would be willing to accept COVID-19 vaccines if they were accessible, whereas 226 participants (54.5%) said they would not accept them if they were . The acceptability of the COVID-19 vaccine was higher in this study than in other countries, with 36.8% in Jordan , 37.2% in Hong Kong , and 34.9% among Jordanian university students . Time or sociodemographic variables could be the likely cause of the divergence between the current outcome and other studies..
The results of this study were better than those of prior global investigations. West Indians' knowledge, attitudes, and behaviors about the acceptance of the COVID-19 vaccine (64.5%) . On the other hand, the finding of this study was lower than the study conducted on public acceptance of COVID-19 in China (83.3–91.3) . The COVID-19 vaccine was accepted by 79% of the people in Israel . Global survey of potential acceptance of a COVID-19 vaccine with 71.5% . 63.5% of respondents in the United Kingdom are willing to accept the COVID-19 vaccine if available .
The study's findings indicate that people without a history of vaccination side effects were more likely to adopt the COVID-19 vaccine if it became available than people with a history of side effects. If the COVID-19 vaccination were made available, participants who smoke cigarettes were more likely to receive it than those who do not. One explanation could be that people who smoke are aware of the possibility of contracting COVID-19. The acceptance of the COVID-19 vaccine was higher among those with media access than among those without. Most of the time, the COVID-19 vaccine was promoted through the media; those who were informed about the vaccine had a better chance of accepting it. Another significant factor was age. The age group between 30 and 49 was more willing to accept the COVID-19 vaccine than other age groups.
According to the results of these investigations, participants' main reasons for refusing to accept the COVID-19 vaccine were their fear of negative side effects and their lack of trustworthiness. The results are consistent with those of other research on fear of adverse effects . For instance, according to a Ghanaian investigation, the main reasons why people refused to receive COVID-19 vaccinations were a lack of information regarding the vaccine's safety and adverse effects. .
5. Conclusion
The findings of this study suggest that the acceptance of a COVID-19 vaccine was good compared to the findings of other studies. Acceptance of the COVID-19 vaccine was significantly correlated with age, use of mass media, history of vaccine adverse effects, friends diagnosed with COVID-19, and cigarette smoking.
6. Recommendation
To the Metekel zone health desk, Communication strategies of the vaccination campaigns should provide clear, simple and detailed messages about the efficacy and the benefits of the COVID-19 vaccines. Engagement of religious organizations and religious leaders to promote the necessary COVID-19 vaccination to their followers.
To Benishangul Gumuz regional health Bearu, with different stakeholders, should strengthen public education using Community radio, about the advantages of getting COVID-19 vaccination, and to access the individuals who are willing to take the vaccine, if available.
7. Limitation
This study is that it is cross-sectional, making it difficult to draw long-term conclusions. The results of this research were solely based on quantitative techniques, with no qualitative data being used to supplement the findings.
Abbreviations

COVID-19

Coronavirus Disease 2019

CCO

Chief Clinical Officer

CEO

Chief Executive Officer

EC

Ethiopian Calendar

HCPs

Health Care Providers

JCVI

Joint Committee on Vaccination

SARS

Severe Acute Respiratory Syndrome

Acknowledgments
We would like to say thank you to Pawi Health Science College. Secondly, great thanks to the Research and Innovation Directorate of the College for building the expertise team for giving us the chance to conduct this research and supporting us in many ways.
Author Contributions
Dereje Getahun Gashaye: Conceptualization, Formal analysis, writing –Original draft, Investigation Methodology
Tamiru Bogale Jemberu: writing, Original draft, Investigation Methodology
Solomon Debela Bekeko: Writing – review & editing, Software
Biratu Ebessa Sedeta: Investigation Methodology
Declaration
I hereby declare that the information given above and in the enclosed document is true to the best of my knowledge and belief, and nothing has been concealed therein. I understand that if the information given by me is proven to be untrue. I will have to face the punishment as per the law.
Availability of Data and Materials
The source of the data is present at the corresponding author upon reasonable request by concerned individuals.
Ethics Approval and Consent
For this research, Ethical clearance was obtained from the Ethical Committee Review Committee of PHSC in Ethiopia. After a formal letter was written to the study area, data collection was started, and verbal consent was obtained from participants.
Funding
PHSC has funded this research.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Imran, M., A. S. Alshrari, and S. M. B. Asdaq, Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review. Journal of Infection and Public Health, 2021. 14(8): p. 1075-1086.
[2] Team, E., The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly, 2020. 2(8): p. 113.
[3] Adhikari, S. P., et al., Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty, 2020. 9: p. 1-12.
[4] Coronavirus, W., Dashboard
[5] Bell, S., et al., COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study. PLoS One, 2022. 17(1): p. e0260949.
[6] Mahase, E., and Covid-19: What do we know about the late stage vaccine candidates? 2020, British Medical Journal Publishing Group.
[7] WHO, 2.2 million COVID-19 vaccines allocated by the COVAX Facility arrive in Ethiopia, marking the start of the country’s COVID-19 vaccination campaign? 2021.
[8] Wassihun, Y., et al., Assessment of COVID-19 vaccine uptake and associated factors among healthcare workers in selected health facilities of the Somali Region, Eastern Ethiopia: a cross-sectional study conducted in 2021. BMJ Public Health, 2024. 2(1).
[9] Mesele, M., COVID-19 vaccination acceptance and its associated factors in Sodo Town, Wolaita Zone, and Southern Ethiopia: cross-sectional study. Infection and Drug Resistance, 2021: p. 2361-2367.
[10] Holmes, E. and Y. Novel, coronavirus genome, 2020 [cited 2020 Apr 5]. 2019, Available.
[11] Gomes, C., Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Brazilian Journal of Implantology and Health Sciences, 2020. 2(3).
[12] Wu, Z. and J. M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. Jama, 2020. 323(13): p. 1239-1242.
[13] Liu, Y., et al., The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine, 2020.
[14] Schuster, M., J. Eskola, and P. Duclos, Review of vaccine hesitancy: Rationale, remit and methods. Vaccine, 2015. 33(34): p. 4157-4160.
[15] Yaqub, O., et al., Attitudes to vaccination: a critical review. Social science & medicine, 2014. 112: p. 1-11.
[16] Fabry, P., A. Gagneur, and J.-C. Pasquier, Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine, 2011. 29(9): p. 1824-1829.
[17] McCarthy, E. M., et al., Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population. JCR: Journal of Clinical Rheumatology, 2012. 18(5): p. 237-241.
[18] Betsch, C. and S. Wicker, E-health use, vaccination knowledge and perception of own risk: drivers of vaccination uptake in medical students. Vaccine, 2012. 30(6): p. 1143-1148.
[19] Korber, B., et al., Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell, 2020. 182(4): p. 812-827. e19.
[20] COVID, W. E., vaccine in a national launching ceremony. 2021.
[21] Tang, X., et al., on the origin and continuing evolution of SARS-CoV-2. National Science Review, 2020. 7(6): p. 1012-1023.
[22] Al-Qerem, W. A. and A. S. Jarab, COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population. Frontiers in Public Health, 2021. 9: p. 632914.
[23] Chen, D., et al., Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. International Journal of Infectious Diseases, 2020. 93: p. 297-299.
[24] Geoghegan, S., K. P. O’Callaghan, and P. A. Offit, Vaccine safety: myths and misinformation. Frontiers in microbiology, 2020. 11: p. 372.
[25] Enitan, S. S., et al., Assessment of knowledge, perception, and readiness of Nigerians to participate in the COVID-19 vaccine trial. International Journal of Vaccines and Immunization, 2020. 4(1): p. 1-13.
Cite This Article
  • APA Style

    Gashaye, D. G., Jemberu, T. B., Bekeko, S. D., Sedeta, B. E. (2025). COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia. Science Journal of Public Health, 13(3), 106-113. https://doi.org/10.11648/j.sjph.20251303.11

    Copy | Download

    ACS Style

    Gashaye, D. G.; Jemberu, T. B.; Bekeko, S. D.; Sedeta, B. E. COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia. Sci. J. Public Health 2025, 13(3), 106-113. doi: 10.11648/j.sjph.20251303.11

    Copy | Download

    AMA Style

    Gashaye DG, Jemberu TB, Bekeko SD, Sedeta BE. COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia. Sci J Public Health. 2025;13(3):106-113. doi: 10.11648/j.sjph.20251303.11

    Copy | Download

  • @article{10.11648/j.sjph.20251303.11,
      author = {Dereje Getahun Gashaye and Tamiru Bogale Jemberu and Solomon Debela Bekeko and Biratu Ebessa Sedeta},
      title = {COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia
    },
      journal = {Science Journal of Public Health},
      volume = {13},
      number = {3},
      pages = {106-113},
      doi = {10.11648/j.sjph.20251303.11},
      url = {https://doi.org/10.11648/j.sjph.20251303.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20251303.11},
      abstract = {Background: The coronavirus killed millions of people globally and was deemed a public health emergency on March 11, 2020. Many nations have put strict regulations in place. Mass vaccinations to protect the public from COVID-19 have been in place since December 2020. To stop viruses from spreading, community immunizations against COVID-19 are crucial. However, there is currently no information available on Gilgel Beles town's community's adoption of the COVID-19 vaccination. Objective: The objective of this study is to assess the level of acceptance of COVID-19 vaccination and its associated factors among communities in Gilgel Beles town, Metekel zone, North West Ethiopia. Methodology: Community-based cross-sectional study was employed between April 20/2022, and May 20/ 2022, in Gilgel Beles town. A systematic random sampling technique was used to choose 418 households in the town. After obtaining the ethical clearance sheet, Data was gathered through face-to-face interviews at their home. Before being moved to SPSS version 22 for analysis, the data were coded, cleaned, recorded, and entered into Epidata 4. The relationship between independent and dependent variables was investigated using bivariate logistic regression analysis. A variable in the multiple logistic regression models with a p-value ≤0.05 was considered statistically significant. Results: Of 415 respondents, above half of them, 255 (61.4%), were accepted to take the COVID-19 vaccine if available. Age (P-value=0.000), History of vaccine adverse effects (AOR=.3.63, 95%, CI: 1.38, 9.55), Cigarette smoking practice (AOR=3.47, 95% CI: 1.45, 8.27), Friends have been diagnosed with COVID-19 (P-value=0.000) and type of media (P=0.016) were significantly associated with acceptance of COVID-19 vaccine. Conclusion: The prevalence of COVID-19 vaccination acceptance was not high enough. The engagement of religious organizations and religious leaders to promote the advantages of COVID-19 vaccination to their followers and promotion through community radio should be implemented to increase COVID-19 vaccination acceptance.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - COVID-19 Vaccine Acceptance and Associated Factors in Gilgel Beles Town, Metekel Zone, Benishangul-Gumuz Region, Northwest Ethiopia
    
    AU  - Dereje Getahun Gashaye
    AU  - Tamiru Bogale Jemberu
    AU  - Solomon Debela Bekeko
    AU  - Biratu Ebessa Sedeta
    Y1  - 2025/05/29
    PY  - 2025
    N1  - https://doi.org/10.11648/j.sjph.20251303.11
    DO  - 10.11648/j.sjph.20251303.11
    T2  - Science Journal of Public Health
    JF  - Science Journal of Public Health
    JO  - Science Journal of Public Health
    SP  - 106
    EP  - 113
    PB  - Science Publishing Group
    SN  - 2328-7950
    UR  - https://doi.org/10.11648/j.sjph.20251303.11
    AB  - Background: The coronavirus killed millions of people globally and was deemed a public health emergency on March 11, 2020. Many nations have put strict regulations in place. Mass vaccinations to protect the public from COVID-19 have been in place since December 2020. To stop viruses from spreading, community immunizations against COVID-19 are crucial. However, there is currently no information available on Gilgel Beles town's community's adoption of the COVID-19 vaccination. Objective: The objective of this study is to assess the level of acceptance of COVID-19 vaccination and its associated factors among communities in Gilgel Beles town, Metekel zone, North West Ethiopia. Methodology: Community-based cross-sectional study was employed between April 20/2022, and May 20/ 2022, in Gilgel Beles town. A systematic random sampling technique was used to choose 418 households in the town. After obtaining the ethical clearance sheet, Data was gathered through face-to-face interviews at their home. Before being moved to SPSS version 22 for analysis, the data were coded, cleaned, recorded, and entered into Epidata 4. The relationship between independent and dependent variables was investigated using bivariate logistic regression analysis. A variable in the multiple logistic regression models with a p-value ≤0.05 was considered statistically significant. Results: Of 415 respondents, above half of them, 255 (61.4%), were accepted to take the COVID-19 vaccine if available. Age (P-value=0.000), History of vaccine adverse effects (AOR=.3.63, 95%, CI: 1.38, 9.55), Cigarette smoking practice (AOR=3.47, 95% CI: 1.45, 8.27), Friends have been diagnosed with COVID-19 (P-value=0.000) and type of media (P=0.016) were significantly associated with acceptance of COVID-19 vaccine. Conclusion: The prevalence of COVID-19 vaccination acceptance was not high enough. The engagement of religious organizations and religious leaders to promote the advantages of COVID-19 vaccination to their followers and promotion through community radio should be implemented to increase COVID-19 vaccination acceptance.
    
    VL  - 13
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Abstract
  • Keywords
  • Document Sections

    1. 1. Background
    2. 2. Methods
    3. 3. Results and Discussion
    4. 4. Discussion
    5. 5. Conclusion
    6. 6. Recommendation
    7. 7. Limitation
    Show Full Outline
  • Abbreviations
  • Acknowledgments
  • Author Contributions
  • Declaration
  • Availability of Data and Materials
  • Ethics Approval and Consent
  • Funding
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information